By Barbara Duckworth, The Western Producer, July 28, 2016
A new vaccine uses mycobaterium cell wall fraction technology to activate an animal’s immune response to E.coli
An alternative to antibiotics has received approval from the Canadian Food Inspection Agency.
Amplimune is a therapeutic immunobiologic product for cattle released by NovaVice Inc., an Ontario company.
